Baxter downgraded at ArgusBAX was downgraded from Buy to Hold, Argus Research said. Company is seeing lower sales in the BioScience segment.
Berry Petroleum initiated at JP MorganBRY initiated at JP Morgan. Initiated with an Overweight rating and $40.50 price target. Introduces 2010 EPS estimates of $4.96.
Cheesecake Factory upgraded at BairdCAKE was upgraded from Neutral to Outperform, Robert Baird said. $32 price target. Company is seeing better sales and traffic trends.
Clearn Channel Outdoor upgraded at Piper JaffrayCCO upgraded at Piper Jaffray. Rating raised to Neutral from Underweight. Price target raised to $12 from $6. 2010 EPS estimates lowered to -$0.11 from -$0.04.
Dean Foods downgraded at UBSDF was downgraded from Buy to Neutral, UBS said. $11 price target. Estimates also lowered, given pricing pressures in the milk market.
Electronic Arts upgraded at MKMERTS was upgraded from Sell to Neutral, MKM Partners said. Company is turning the business around and seeing better sales from ints new titles.
Legg Mason upgraded at BofA/MerrillLM upgraded to Neutral from Underperform on cost savings, large buyback and better flows, Bank of America/Merrill Lynch said. Price target maintained at $31.
Nektar Therapeutics downgraded at BarclaysNKTR downgraded to Equal Weight from Overweight on valuation, Barclays said. Maintain $14 price target.
MetroPCS upgraded at DeutschePCS was upgraded from Hold to Buy, Deutsche Bank said. $14 price target. New plans should drive subscriber growth.
Petsmart rated new Buy at JefferiesPETM was initiated with a Buy rating, Jefferies said. $39 price target. Company should benefit from a resurgence in discretionary spending.
Primerica rated new Neutral at UBSPRI was initiated with a Neutral rating, UBS said. $27 price target. Company can deliver double-digit earnings growth by 2012, but faces compliance issues.
Red Hat upgraded at JefferiesRHT was upgraded from Hold to Buy, Jefferies said. $35 price target. Company is seeing a rebound in server shipments and better pricing.
SS&C Technologies rated new Buy at DeutscheSSNC was initiated with a Buy rating, Deutsche Bank said. $19 price target. Industry trends are improving and organic growth could accelerate.
St Jude Medical upgraded at Piper JaffraySTJ upgraded at Piper Jaffray. Rating raised to Overweight from Neutral. Maintains $44 price target and 2010 EPS estimates of $2.84.
Talbots initiated at BarclaysTLB initiated with an Overweight rating and $23 price target. Sales are recovering broadly and the TLB story is just getting started, Barclays said.
Tyson Foods estimates increased at Morgan StanleyTSN estimates were raised through 2011, Morgan Stanley said. Protein market is improving and the company is seeing better operating efficiency. Equal-weight rating.
Tyson Foods downgraded at Credit SuisseTSN downgraded to Neutral from Outperform. Valuation call. Price target lowered to $21 from $23.
Shares of AAPL now seen reaching $320, according to Kaufman Bros. Estimates also increased, given higher expected Mac and iPad sales. Buy rating.
Arena Resources estimates raised at UBS
ARNA estimates were increased through 2011, UBS said. Company is seeing an improvement in production. Buy rating and $40 price target.
Arena Resources estimates raised at UBSARNA estimates were increased through 2011, UBS said. Company is seeing an improvement in production. Buy rating and $40 price target.
BioMed Realty numbers boosted at Credit SuisseBMR price target lifted by a dollar to $17 on solid 1Q10 earnings, Credit Suisse said. Estimates raised through 2012. Maintain Neutral rating.
Boyd Gaming estimates, target raised at GoldmanShares of BYD now seen reaching $12, according to Goldman Sachs said. Estimates also increased, as the company is seeing better results in Las Vegas. Neutral rating.
Chesapeake Energy estimates lowered at GoldmanCHK estimates were cut through 2012, Goldman Sachs said. Asset sales and higher share count will hurt profits. Neutral rating and $30 price target.
Coach estimates lowered at GoldmanCOH estimates were cut through 2012, Goldman Sachs said. Company has exposure to the lower Yen. Neutral rating.
Discovery Communications target upped at Morgan StanleyDISCA target was boosted to $42, Morgan Stanley said. Company can deliver organic growth and is buying back stock. Equal-weight rating and $42 price target.
Dish Network estimates boosted at GoldmanDISH estimates were upped through 2012, according to Goldman Sachs. Company is seeing higher subscriber growth. Sell rating and $18 price target.
Fluor estimates reduced at UBSFLR estimates were cut through 2011, UBS said. Company reported a lower backlog this quarter. Buy rating and $60 price target.
Fluor target, estimates tweaked at BarclaysFLR price target lowered a dollar to $58 on mixed 1Q10 results, Barclays said. 2010 and 2011 EPS estimates trimmed to $2.85 and $3.20, respectively.
FMC estimates, target upped at UBSFMC estimates were boosted through 2011, UBS said. Soda Ash market is gaining momentum. Buy rating and new $73 price target.
Quicksilver Resources estimates increased at UBSKWK estimates were raised through 2011, UBS said. Company is realizing higher prices and spending less on CapEx. Buy rating and $16 price target.
Legg Mason target, estimates higher at CitiLM price target increased to $33.50 from $29.50 to reflect cost-reductions and share repurchases, Citigroup said. Estimates lifted through 2012. Maintain Hold rating.
Legg Mason estimates increased at FBRLM estimates were raised through 2012, FBR Capital Markets said. Buybacks should offset restructuring costs. Market Perform rating and $33 price target.
K12 price target higher at Credit SuisseLRN price target raised by a dollar to $21 on strong 3Q10 results, Credit Suisse said. Estimates increased through 2012. Maintain Neutral rating.
Marathon Oil estimate raised at BarclaysMRO 2010 EPS estimates jumped to $3.10, 2011 held at $4.30. Oil discovered in the Flying Dutchman area, Barclays said. Maintain Equal Weight rating and $34 price target.
Nuance Communications numbers boosted at FBRShares of NUAN now seen reaching $21, according to FBR Capital Markets. Estimates also upped, as the company is posting double-digit organic growth. Outperform rating.
Priceline.com price target cut at BofA/MerrillPCLN price target lowered to $270 from $300 on mixed 1Q10 results, Bank of America/Merrill Lynch said. Estimates lowered through 2011. Reiterate Buy rating.
Priceline.com numbers lowered at GoldmanShares of PCLN now seen reaching $260, according to Goldman Sachs. Estimates also cut, given the weaker Euro and travel delays from the volcanic ash. Neutral rating.
Philip Morris estimates lowered at Morgan StanleyPM estimates were reduced through 2012, according to Morgan Stanley. Company has significant exposure to Europe. Overweight rating and $57 price target.
Ralph Lauren numbers cut at GoldmanShares of RL now seen reaching $101, according to Goldman Sachs. Estimates also reduced, given the company's currency exposure in Europe. Buy rating.
Charles Schwab estimates reduced at Morgan StanleySCHW estimates were cut through 2011, Morgan Stanley said. Rate hikes will likely came later than expected. Overweight rating and $21 price target.
Scripps Networks target raised at Morgan StanleyShares of SNI now seen reaching $52, according to Morgan Stanley. Company is seeing better rating and should benefit from an advertising recovery. Equal-weight rating.
Tiffany estimates, target reduced at GoldmanTIF estimates were cut through 2012, Goldman Sachs said. Company has heavy exposure to Asia and Europe. Neutral rating and new $52 price target.
TJX Companies estimates lowered at GoldmanTJX estimates were reduced through 2012, according to Goldman Sachs. Company is being hurt by the weaker Pound and Euro. Buy rating.
Wal-Mart estimates cut at GoldmanWMT estimates were reduced through 2012, Goldman Sachs said. Company seeing impact from the weaker Pound and Yen. Buy rating.
Watson Pharmaceuticals estimates boosted at UBSWPI estimates were upped through 2011, according to UBS. Company has a strong pipeline on both sides of the business. Neutral rating and $43 price target.
